The enrichment analysis of 51 potential targets indicated that these targets could be applied to treat COVID-19 by activating broad spectrum antiviral, immune regulatory, and inflammatory responses through the regulation of the Coronavirus disease—COVID-19, cytokine-cytokine receptor interaction, IL-17 signaling pathway, and others. The gene discussed is IL17A; the disease is COVID-19.